| Tranquil Shores Llc | |
|
4300 Duhme Rd Fl 2 Madeira Beach FL 33708-2876 | |
| (727) 391-7001 | |
| (727) 391-3125 |
| Full Name | Tranquil Shores Llc |
|---|---|
| Speciality | Clinic/center - Rehabilitation, Substance Use Disorder |
| Location | 4300 Duhme Rd Fl 2, Madeira Beach, Florida |
| Authorized Official Name and Position | Chad Johnson (CEO) |
| Authorized Official Contact | 7273917001 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Tranquil Shores Llc 4300 Duhme Rd Fl 2 Madeira Beach FL 33708-2876 Ph: (727) 391-7001 | Tranquil Shores Llc 4300 Duhme Rd Fl 2 Madeira Beach FL 33708-2876 Ph: (727) 391-7001 |
| NPI Number | 1730496126 |
|---|---|
| Provider Enumeration Date | 09/07/2010 |
| Last Update Date | 03/17/2016 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730496126 | NPI | - | NPPES |
News Archive
In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it.
WebMD Health Corp. announced today the final results of its tender offer to purchase up to 5,800,000 shares of its common stock at a price of $46.80 per share, which expired at 5:00 p.m., New York City time on April 8, 2010. Based on the final tabulation by American Stock Transfer & Trust Company, the Depositary for the tender offer, 5,172,204 shares of WebMD common stock were properly tendered and delivered.
Novavax, Inc. and Xcellerex, Inc. have entered into a strategic collaboration to accelerate the development of Novavax's vaccine manufacturing process to commercial scale and begin immediate production of Novavax's novel 2009 H1N1 influenza vaccine for potential commercial sale.
"What will the day be like when we finally defeat AIDS, tuberculosis and malaria?" Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post's "The Big Push" blog.
› Verified 8 days ago